OptiNose

OptiNose is a Pennsylvania-based pharmaceutical company that develops and commercializes therapeutic products for the treatment of ENT problems and allergies.

Business Model:

Revenue: $77.9M

Employees: 51-200

Detailed OptiNose Information

Geographic Data

OptiNose headquarters map

Address: 1020 Stony Hill Road

City: Yardley

State: PA

Zip: 19067

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$150M

Raised Total:

$401M

Metrics

3,310,147Website Global Rank

4,564Website Monthly Traffic

Twitter Followers

Description

OptiNose is a Pennsylvania-based pharmaceutical company that develops and commercializes therapeutic products for the treatment of ENT problems and allergies.

Contact Phone:
+12673643500

Contact Email:

OptiNose went public on 10/17/2017 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/17/2017

IPO Valuation:
$604M

Ticker Symbol:
OPTN

IPO Price:
$16/share

Amount Raised:
$138M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
8/2014 Series C $0 Avista Capital Partners
Entrepreneurs Fund
WFD Ventures
Avista Capital Partners
Entrepreneurs Fund
WFD Ventures
6/2010 Private Equity Round $0 Avista Capital Partners
WFD Ventures
Avista Capital Partners
WFD Ventures
12/2002 Seed Round 1 $933.5k Oxygen House
Oxygen House
12/2002 Funding Round $0 Oxygen House
Oxygen House
5/2017 Series D $0 Avista Capital Partners
Fidelity Management and Research Company
Entrepreneurs Fund
Fidelity Management and Research Company
Avista Capital Partners
Fidelity Management and Research Company
Entrepreneurs Fund
Fidelity Management and Research Company
10/2015 Series C $0 Avista Capital Partners
The Entrepreneurs&s; Fund
WFD Ventures
Avista Capital Partners
The Entrepreneurs&s; Fund
WFD Ventures
9/2020 Post-IPO Debt 1 $150M Pharmakon Advisors
Pharmakon Advisors
Pharmakon Advisors
Pharmakon Advisors
11/2021 Post-IPO Equity $4M
1/2018 Post-IPO Debt 1 $100M Athyrium Capital Management LP
Athyrium Capital Management LP
Athyrium Capital Management LP
Athyrium Capital Management LP
9/2019 Equity $5.4M
11/2021 Post-IPO Equity $46M
9/2019 Debt $150M Pharmakon Advisors, LP
11/2022 Post-IPO Equity $50M
5/2017 Series D 3 $37M Avista Capital Partners
Fidelity Management and Research Company
Entrepreneurs Fund
Fidelity Management and Research Company
Avista Capital Partners
Fidelity Management and Research Company
Entrepreneurs Fund
Fidelity Management and Research Company
10/2015 Series C 3 $30M Avista Capital Partners
The Entrepreneurs&s; Fund
WFD Ventures
Avista Capital Partners
The Entrepreneurs&s; Fund
WFD Ventures
8/2014 Series C 3 $35M Avista Capital Partners
Entrepreneurs Fund
Avista Capital Partners
Entrepreneurs Fund
6/2010 Private Equity Round 2 $48.5M Avista Capital Partners
Avista Capital Partners
12/2002 Funding Round 1 $933.5k
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research